Literature DB >> 14660745

A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons.

Theron A Russell1, Masafumi Ito, Mika Ito, Richard N Yu, Fred A Martinson, Jeffrey Weiss, J Larry Jameson.   

Abstract

Familial neurohypophyseal diabetes insipidus (FNDI) is an autosomal dominant disorder caused by mutations in the arginine vasopressin (AVP) precursor. The pathogenesis of FNDI is proposed to involve mutant protein-induced loss of AVP-producing neurons. We established murine knock-in models of two different naturally occurring human mutations that cause FNDI. A mutation in the AVP signal sequence [A(-1)T] is associated with a relatively mild phenotype or delayed presentation in humans. This mutation caused no apparent phenotype in mice. In contrast, heterozygous mice expressing a mutation that truncates the AVP precursor (C67X) exhibited polyuria and polydipsia by 2 months of age and these features of DI progressively worsened with age. Studies of the paraventricular and supraoptic nuclei revealed induction of the chaperone protein BiP and progressive loss of AVP-producing neurons relative to oxytocin-producing neurons. In addition, Avp gene products were not detected in the neuronal projections, suggesting retention of WT and mutant AVP precursors within the cell bodies. In summary, this murine model of FNDI recapitulates many features of the human disorder and demonstrates that expression of the mutant AVP precursor leads to progressive neuronal cell loss.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14660745      PMCID: PMC281642          DOI: 10.1172/JCI18616

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

Review 1.  Neurodegeneration: what is it and where are we?

Authors:  Serge Przedborski; Miquel Vila; Vernice Jackson-Lewis
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Familial neurohypophysial diabetes insipidus in a large Dutch kindred: effect of the onset of diabetes on growth in children and cell biological defects of the mutant vasopressin prohormone.

Authors:  M Nijenhuis; E L van den Akker; R Zalm; A A Franken; A P Abbes; H Engel; D de Wied; J P Burbach
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

3.  A new type of familial central diabetes insipidus caused by a single base substitution in the neurophysin II coding region of the vasopressin gene.

Authors:  Y Ueta; S Taniguchi; A Yoshida; I Murakami; Y Mitani; I Hisatome; I Manabe; R Sato; M Tsuboi; A Ohtahara; E Nanba; C Shigemasa
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

4.  Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus.

Authors:  M Ito; Y Oiso; T Murase; K Kondo; H Saito; T Chinzei; M Racchi; M O Lively
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

5.  Two cases of hereditary diabetes insipidus, with an autopsy finding in one.

Authors:  I Nagai; C H Li; S M Hsieh; T Kizaki; Y Urano
Journal:  Acta Endocrinol (Copenh)       Date:  1984-03

6.  Identification of a novel mutation in the arginine vasopressin-neurophysin II gene in familial central diabetes insipidus.

Authors:  C Bullmann; J Kotzka; T Grimm; C Heppner; F Jockenhövel; W Krone; D Müller-Wieland
Journal:  Exp Clin Endocrinol Diabetes       Date:  2002-05       Impact factor: 2.949

7.  Glu-47, which forms a salt bridge between neurophysin-II and arginine vasopressin, is deleted in patients with familial central diabetes insipidus.

Authors:  H Yuasa; M Ito; H Nagasaki; Y Oiso; S Miyamoto; N Sasaki; H Saito
Journal:  J Clin Endocrinol Metab       Date:  1993-09       Impact factor: 5.958

8.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.

Authors:  A Nagy; J Rossant; R Nagy; W Abramow-Newerly; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Detection of a novel arginine vasopressin defect by dideoxy fingerprinting.

Authors:  M R Krishnamani; J A Phillips; K C Copeland
Journal:  J Clin Endocrinol Metab       Date:  1993-09       Impact factor: 5.958

10.  Two novel mutations of the vasopressin gene associated with familial diabetes insipidus and identification of an asymptomatic carrier infant.

Authors:  F D Grant; A Ahmadi; C M Hosley; J A Majzoub
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

View more
  20 in total

1.  Oxidoreductase interactions include a role for ERp72 engagement with mutant thyroglobulin from the rdw/rdw rat dwarf.

Authors:  Shekar Menon; Jaemin Lee; William A Abplanalp; Sung-Eun Yoo; Takashi Agui; Sen-Ichi Furudate; Paul S Kim; Peter Arvan
Journal:  J Biol Chem       Date:  2007-01-02       Impact factor: 5.157

Review 2.  Familial forms of diabetes insipidus: clinical and molecular characteristics.

Authors:  Muriel Babey; Peter Kopp; Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-07-05       Impact factor: 43.330

3.  A novel heterozygous missense mutation in the vasopressin moiety is identified in a Japanese person with neurohypophyseal diabetes insipidus.

Authors:  H Kobayashi; I Fujisawa; K Ikeda; C Son; T Iwakura; A Yoshimoto; M Kasahara; T Ishihara; Y Ogawa
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

Review 4.  Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 5.  Lessons from animal models of endocrine disorders caused by defects of protein folding in the secretory pathway.

Authors:  Yoshiaki Morishita; Peter Arvan
Journal:  Mol Cell Endocrinol       Date:  2019-10-09       Impact factor: 4.102

6.  ER-associated degradation is required for vasopressin prohormone processing and systemic water homeostasis.

Authors:  Guojun Shi; Diane RM Somlo; Geun Hyang Kim; Cristina Prescianotto-Baschong; Shengyi Sun; Nicole Beuret; Qiaoming Long; Jonas Rutishauser; Peter Arvan; Martin Spiess; Ling Qi
Journal:  J Clin Invest       Date:  2017-09-18       Impact factor: 14.808

7.  Mice deficient for ERAD machinery component Sel1L develop central diabetes insipidus.

Authors:  Daniel G Bichet; Yoann Lussier
Journal:  J Clin Invest       Date:  2017-09-18       Impact factor: 14.808

8.  AVP-NPII gene mutations and clinical characteristics of the patients with autosomal dominant familial central diabetes insipidus.

Authors:  Doga Turkkahraman; Emel Saglar; Tugce Karaduman; Hatice Mergen
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

9.  Polyuria and polydipsia in a young child: diagnostic considerations and identification of novel mutation causing familial neurohypophyseal diabetes insipidus.

Authors:  Matthew D Stephen; Raymond G Fenwick; Patrick G Brosnan
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

10.  Dominant-negative diabetes insipidus and other endocrinopathies.

Authors:  John A Phillips
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.